Clinical Trial Detail

NCT ID NCT03050060
Title Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, and Nivolumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington

lung non-small cell carcinoma


renal carcinoma


Nelfinavir + Nivolumab

Age Groups: adult senior

No variant requirements are available.